Search research articles
Contact Us
Filters
Showing results (101-110 of 299) with videos related to
Page
of 30
Sort By:
Blood Reviews
|
August 31, 2015
Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Javeed Iqbal, Ryan Wilcox, Hina Naushad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes
Julie M Vose, Laura A Levit, Patricia Hurley, et al.
Leukemia & Lymphoma
|
October 11, 2014
Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphoma
Kyriakos P Papadopoulos, Coumaran Egile, Rodrigo Ruiz-Soto, et al.
Cancer
|
July 29, 2010
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma
Richard R Furman, Peter Martin, Jia Ruan, et al.
British Journal of Haematology
|
October 1, 2010
Late relapse in patients with diffuse large B-cell lymphoma
Julie M Vose, Dennis D Weisenburger, Fausto R Loberiza, et al.
British Journal of Haematology
|
April 25, 2023
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study
Julie M Vose, Siddhartha Ganguly, Philip J Bierman, et al.
Leukemia & Lymphoma
|
February 28, 2007
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma
Julie M Vose, Amit Panwalkar, Robert Belanger, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 31, 2015
Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades
Vijaya Raj Bhatt, Fausto R Loberiza, Hongmei Jing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 16, 2010
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response
Marcie R Tomblyn, Marian Ewell, Christopher Bredeson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 4, 2012
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma
Julie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
Page
of 30
Search research articles
Search
Showing results (101-110 of 299) with videos related to
Sort By:
Page
of 30
Blood Reviews
|
August 31, 2015
Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Javeed Iqbal, Ryan Wilcox, Hina Naushad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes
Julie M Vose, Laura A Levit, Patricia Hurley, et al.
Leukemia & Lymphoma
|
October 11, 2014
Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphoma
Kyriakos P Papadopoulos, Coumaran Egile, Rodrigo Ruiz-Soto, et al.
Cancer
|
July 29, 2010
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma
Richard R Furman, Peter Martin, Jia Ruan, et al.
British Journal of Haematology
|
October 1, 2010
Late relapse in patients with diffuse large B-cell lymphoma
Julie M Vose, Dennis D Weisenburger, Fausto R Loberiza, et al.
British Journal of Haematology
|
April 25, 2023
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study
Julie M Vose, Siddhartha Ganguly, Philip J Bierman, et al.
Leukemia & Lymphoma
|
February 28, 2007
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma
Julie M Vose, Amit Panwalkar, Robert Belanger, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 31, 2015
Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades
Vijaya Raj Bhatt, Fausto R Loberiza, Hongmei Jing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 16, 2010
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response
Marcie R Tomblyn, Marian Ewell, Christopher Bredeson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 4, 2012
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma
Julie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
Page
of 30